Login

Paul Grint Discusses AmpliPhi Biosciences - Paul Grint, CEO, AmpliPhi Biosciences Corp 00:00:00

Share On Facebook Share On Twitter

Paul Grint Discusses AmpliPhi Biosciences

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Fostering Societal Contribution Beyond Profit: A Call for Wildlife Conservation |Harald Link, CEO, B Grimm Power PCL.
00:10:00
Air Canada's Commitment to Net-Zero: Insights from CEO Michael Rousseau | Michael Rousseau, CEO, Air Canada.
00:10:00
Keystone Global Network Made My Application Process to the University of Georgia Smooth and Successful
00:10:00
Mr. Zelter on Apollo Global Management's Credit Strategy: High-Yield Nearing 10% Seen as 'Attractive'"
00:10:00
Diamond Miner with Strategic Alliance with Tiffany & Co. Nears Production
00:10:00
EEI interviews NorthWestern Energy's President and CEO Bob Rowe to explore his insights on the future of technology, regulation, and energy trends.
00:10:00
NCC Group - Shaping the Future of Cyber Security | Mike Maddison, CEO, NCC Group PLCNCC:LSE
00:10:00
Investment Dollars and Impact Initiatives for an Inclusive Economy | U.S. Small Business Administration (SBA)
00:10:00
The Global Venture Market will the VC funding decline stifle innovation|Amy Cheetham,Partner,Costanoa Ventures
00:00:00
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:10:00
Tetra Tech CEO Highlights Company’s Consistent Focus on Empowering Innovative Solutions
00:00:00
Michael Goldberg, President & CEO of Navidea Biopharmaceuticals, Inc.

© 2017 - Neuhu+